-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Eucrates Biomedical Acquisition Corp. quarterly/annual Return On Equity history and growth rate from 2021 to 2022.
- Eucrates Biomedical Acquisition Corp. Return On Equity for the quarter ending December 31, 2022 was -62.8 %, a 3.63% decline year-over-year.
- Eucrates Biomedical Acquisition Corp. annual Return On Equity for 2022 was -62.8 %, a 3.63% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)